Skip to main content

Table 2 Function and bother scores (mean ± standard deviation; median) in dependence on age group

From: Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment

  ≤65 years 66-70 years 71-75 years >75 years
urinary function 94 ± 13; 100 92 ± 15; 100 91 ± 14; 100 92 ± 12; 94
continence function* 92 ± 18; 100 88 ± 21; 100 85 ± 23; 100 87 ± 20; 94
irritative/obstructive function 95 ± 13; 100 97 ± 12; 100 98 ± 10; 100 98 ± 9; 94
urinary bother† 82 ± 20; 89 84 ± 20; 91 82 ± 18; 89 79 ± 19; 86
continence bother 93 ± 22; 100 90 ± 25; 100 90 ± 25; 100 90 ± 22; 100
irritative/obstructive bother 80 ± 20; 90 83 ± 20; 90 81 ± 18; 85 79 ± 18; 83
bowel function 91 ± 11; 96 93 ± 9; 96 93 ± 9; 96 93 ± 9; 96
bowel bother 93 ± 14; 100 93 ± 14; 100 95 ± 10; 100 93 ± 13; 100
sexual function 48 ± 25; 50 43 ± 23; 50 35 ± 23; 32 30 ± 24; 28
sexual bother 68 ± 32; 75 64 ± 34; 75 56 ± 36; 56 60 ± 33; 63
hormonal function § 88 ± 17; 100 91 ± 16; 100 92 ± 13; 100 95 ± 10; 100
hormonal bother 89 ± 16; 96 91 ± 15; 100 92 ± 14; 96 94 ± 11; 100
  1. *significant difference ≤65 vs. 71-75/>75 years (p < 0.01)
  2. † significant difference 66-70 vs. >75 years (p < 0.01)
  3. ‡ significant difference ≤65 vs. 71-75/>75 and 66-70 vs. 71-75/>75 years (p < 0.01)
  4. § significant difference ≤65 vs. >75 years (p = 0.03)